Association of 5-HT1B receptor polymorphisms with the loudness dependence of auditory evoked potentials in a community-based sample of healthy volunteers

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 147, Issue 4, 2008, Pages 454-458

  Juckel, Georg ^a,b   Hegerl, Ulrich ^b   Giegling, Ina ^b   Mavrogiorgou, Paraskevi ^a,b   Wutzler, Alexander ^a   Schuhmacher, Christiane ^a   Uhl, Idun ^a   Brüne, Martin ^a   Mulert, Christoph ^b   Pogarell, Oliver ^b   Rujescu, Dan ^b  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

5 HT1B; Auditory evoked potentials; HTR1B; Loudness dependence; Polymorphism; SNP

Indexed keywords

SEROTONIN; SEROTONIN 1B RECEPTOR;

ADDICTION; ALLELE; ARTICLE; AUDITORY CORTEX; DEPRESSION; EVOKED AUDITORY RESPONSE; GENETIC POLYMORPHISM; HAPLOTYPE; HUMAN; HUMAN EXPERIMENT; LOUDNESS; MENTAL DISEASE; NEGATIVE FEEDBACK; NEUROTRANSMISSION; NORMAL HUMAN; OBSESSIVE COMPULSIVE DISORDER; PRIORITY JOURNAL; SEROTONIN RELEASE; SEROTONINERGIC SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM;

ACOUSTIC STIMULATION; ALLELES; EPIDEMIOLOGY; EVOKED POTENTIALS, AUDITORY; GERMANY; HAPLOTYPES; POLYMORPHISM, GENETIC; RECEPTOR, SEROTONIN, 5-HT1B; SEROTONIN;

EID: 45149087834     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30628     Document Type: Article

References (51)

1. Arato M, Frecska E, Maccrimmon DJ, Guscott R, Saxena B, Tekes K, et al. 1991a. Serotonergic interhemispheric asymmetry: Neurochemical and pharmaco-EEG evidence. Prog Neuropsychopharmacol Biol Psychiatry 15(6):759-764.
2. Arato M, Frecska E, Tekes K, MacCrimmon DJ. 1991b. Serotonergic interhemispheric asymmetry: Gender difference in the orbital cortex. Acta Psychiatr Scand 84(1):110-111.
3. Azmitia EC, Gannon PJ. 1986. The primate serotonergic system: A review of human and animal studies and a report on Macaca fascicularis. Adv Neurol 43:407-468.
4. Barrett JC, Fry B, Maller J, Daly MJ. 2005. Haploview: Analysis and visualization of LDAEP and haplotype maps. Bioinformatics 21(2):263-265.
5. Bergqvist PB, Bouchard C, Blier P. 1999. Effect of long-term administration of antidepressant treatments on serotonin release in brain regions involved in obsessive-compulsive disorder. Biol Psychiatry 45(2):164-174.
6. Camarena B, Aguilar A, Loyzaga C, Nicolini H. 2004. A family-based association study of the 5-HT-1Dbeta receptor gene in obsessive-compulsive disorder. Int J Neuropsychopharmacol 7(1):49-53.
7. El Mansari M, Bouchard C, Blier P. 1995. Alteration of serotonin release in the guinea pig orbitofrontal cortex by selective serotonin reuptake inhibitors. Relevance to treatment of obsessive-compulsive disorder. Neuropsychopharmacol 13(2):117-127.
8. El Mansari M, Blier P. 2006. Mechanisms of action of current and potential pharmacotherapies of obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry 30(3):362-373.
9. Fehr C, Grintschuk N, Szegedi A, Anghelescu I, Klawe C, Singer P, et al. 2000. The HTR1B 861G>C receptor polymorphism among patients suffering from alcoholism, major depression, anxiety disorders and narcolepsy. Psychiatry Res 97(1):1-10.
10. First MB, Spitzer RL, Gibbon M, Williams JBW. 1997. Structured clinical interview for DSM-IV Axis I and II Disorders. Washington, DC: American Psychiatric Press.
11. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, et al. 2002. The structure of haplotype blocks in the human genome. Science 296(5576):2225-2229.
12. Gallinat J, Bottlender R, Juckel G, Munke-Puchner A, Stotz G, Kuss HJ, et al. 2000. The loudness dependency of the auditory evoked N1/P2-component as a predictor of the acute SSRI response in depression. Psychopharmacol 148(4):404-411.
13. Gallinat J, Senkowski D, Wernicke C, Juckel G, Becker I, Sander T, et al. 2003. Allelic variants of the functional promoter polymorphism of the human serotonin transporter gene is associated with auditory cortical stimulus processing. Neuropsychopharmacol 28:530-532.
14. Hawi Z, Dring M, Kirley A, Foley D, Kent L, Craddock N, et al. 2002. Serotonergic system and attention deficit hyperactivity disorder (ADHD): A potential susceptibility locus at the 5-HT(1B) receptor gene in 273 nuclear families from a multi-centre sample. Mol Psychiatry 7(7):718-725.
15. Hegerl U, Bottlender R, Gallinat J, Kuss HJ, Ackenheil M, Moller HJ. 1998. The serotonin syndrome scale: First results on validity. Eur Arch Psychiatry Clin Neurosci 248(2):96-103.
16. Hegerl U, Gallinat J, Mrowinski D. 1994. Intensity dependence of auditory evoked dipole source activity. Int J Psychophysiol 17(1):1-13.
17. Hegerl U, Juckel G. 1993. Intensity dependence of auditory evoked potentials as an indicator of central serotonergic neurotransmission: A new hypothesis. Biol Psychiatry 33(3):173-187.
18. Hegerl U, Lipperheide K, Juckel G, Schmidt LG, Rommelspacher H. 1995. Antisocial tendencies and cortical sensory-evoked responses in alcoholism. Alcohol Clin Exp Res 19(1):31-36.
19. Hensch T, Wargelius H-L, Herold U, Lesch K-P, Oreland L, Brocke B. 2006. Further evidence for an association of 5-HTTLPR with intensity dependence of auditory-evoked potentials. Neuropsychopharmacol 31(9):2047-2054.
20. Heymann I, Mataix-Cols D, Fineberg NA. 2006. Obsessive-compulsive disorder. BMJ 333(7565):424-429.
21. Huang YY, Grailhe R, Arango V, Hen R, Mann JJ. 1999. Relationship of psychopathology to the human serotonin 1B genotype and receptor binding kinetics in postmortem brain tissue. Neuropsychopharmacol 21(2):238-246.
22. Huang YY, Oquendo MA, Friedman JM, Greenhill LL, Brodsky B, Malone KM, et al. 2003. Substance abuse disorder and major depression are associated with the human 5-HT1B receptor gene (HTR1B) G861C polymorphism. Neuropsychopharmacol 28(1):163-169.
23. Jacobs BL, Azmitia EC, 1992. Structure and function of the brain serotonin system. Physiol Rev 72(1):165-229.
24. Juckel G, Csepe V, Molnar M, Hegerl U, Karmos G, 1996. Intensity dependence of auditory evoked potentials in behaving cats. Electroenecephal Clin Neurophysiol 100(6):527-537.
25. Juckel G, Gallinat J, Riedel M, Sokullu S, Schulz C, Moller HJ, et al. 2003. Serotonergic dysfunction in schizophrenia assessed by the loudness dependence measure of primary auditory cortex evoked activity. Schizophr Res 64:115-124.
26. Juckel G, Gudlowski Y, Müller D, Özgürdal S, Brüne M, Gallinat J, Frodl T, Witthaus H, Uhl I, Wutzler A, Pogarell O, Mulert C, Hegerl U, Meisenzahl EM. 2007. Loudness dependence of the auditory evoked N1/P2-component as an indicator of serotonergic dysfunction in patients with schizophrenia - A replication study. Psychiatry Res (in press).
27. Juckel G, Hegerl U, Molnar M, Csepe V, Karmos G. 1999. Auditory evoked potentials reflect serotonergic neuronal activity - A study in behaving cats administered drugs acting on 5-HT1A autoreceptors in the dorsal raphe nucleus. Neuropsychopharmacol 21(6):710-716.
28. Juckel G, Mavrogiorgou P, Bredemeier S, Gallinat J, Frodl T, Schulz C, et al. 2004. Loudness dependence of primary auditory-cortex-evoked activity as predictor of therapeutic outcome to prophylactic lithium treatment in affective disorders - A retrospective study. Pharmacopsychiatry 37:46-51.
29. Juckel G, Molnár M, Hegerl U, Csépe V, Karmos G. 1997. Auditory-evoked potentials as indicator of brain serotonergic activity first evidence in behaving cats. Biol Psychiatry 41(12):1181-1195.
30. Juckel G, Hegerl U, Giegling I, Mavrogiorgou P, Gallinat J, Augustin H, Mulert C, Pogarell O, Rujescu D. 2007. Loudness dependence of auditory evoked potentials is not associated with polymorphisms or haplotypes in the serotonin transporter gene in a community-based sample of German healthy volunteers. Psychiatry Res [Epub ahead of print].
31. Lewis DA, Campbell MJ, Foote SL, Morrison JH. 1986. The monoaminergic innervation of primate neocortex. Human Neurobiol 5:181-188.
32. Lochner C, Stein DJ. 2006. Does work on obsessive-compulsive spectrum disorders contribute to understanding the heterogeneity of obsessive-compulsive disorder? Prog Neuropsychopharmacol Biol Psychiatry 30(3):353-361.
33. Moret C, Briley M. 2000. The possible role of 5-HT(1B/D) receptors in psychiatric disorders and their potential as a target for therapy. Eur J Pharmacol 404(1-2):1-12.
34. Mundo E, Richter MA, Sam F, Macciardi F, Kennedy JL. 2000. Is the 5-HT(1Dbeta) receptor gene implicated in the pathogenesis of obsessive-compulsive disorder? Am J Psychiatry 157(7):1160-1161.
35. Mundo E, Richter MA, Zai G, Sam F, McBride J, Macciardi F, et al. 2002. 5HT1Dbeta receptor gene implicated in the pathogenesis of obsessive-compulsive disorder: Further evidence from a family-based association study. Mol Psychiatry 7(7):805-809.
36. Pogarell O, Tatsch K, Juckel G, Hamann C, Mulert C, Popperl G, Folkerts M, Chouker M, Riedel M, Zaudig M, Moller HJ, Hegerl U. 2004. Serotonin and dopamine transporter availabilities correlate with the loudness dependence of auditory evoked potentials in patients with obsessive-compulsive disorder. Neuropsychopharmacology 29(10):1910-1917.
37. Proietti-Cecchini A, Afra J, Schoenen J. 1997. Intensity dependence of the cortical auditory evoked potentials as a surrogate marker of central nervous system serotonin transmission in man: demonstration of a central effect for the 5HT1B/1D agonist zolmitriptan (311C90, Zomig). Cephalalgia 17(8):849-854.
38. Rice JP, Reich T, Bucholz KK, Neuman RJ, Fishman R, Rochberg N. 1995. Comparison of direct interview and family history diagnoses of alcohol dependence. Alcohol Clin Exp Res 19:1018-1023.
39. Roon KI, Sandor PS, Schoonman GG, Lamers FP, Schoenen J, Ferrari MD, et al. 1999. Auditory evoked potentials in the assessment of central nervous system effects of antimigraine drugs. Cephalalgia 19:880-885.
40. Rujescu D, Giegling I, Sato T, Moller HJ. 2003. Lack of association between serotonin 5-HT1B receptor gene polymorphism and suicidal behavior. Am J Med Genet Part B Neuropsychiatr Genet 116B(1):69-71.
41. Sanders AR, Cao Q, Taylor J, Levin TE, Badner JA, Cravchik A, et al. 2001. Genetic diversity of the human serotonin receptor 1B (HTR1B) gene. Genomics 72(1):1-14.
42. Sari Y. 2004. Serotonin 1B receptors: From protein to physiological function and behavior. Neurosci Biobehav Rev 28(6):565-582.
43. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA. 2002. Score tests for association of traits with haplotypes when linkage phase is ambiguous. Am J Hum Genet 70(2):425-434.
44. Scherg M, Picton TW. 1991. Separation and identification of event-related potential components by brain electric source analysis. Electroencephalogr Clin Neurophysiol Suppl 42:24-37.
45. Scherg M, von Cramon D. 1990. Dipole source potentials of the auditory cortex in normal subjects and in patients with temporal lobe lesions. Adv Audiol 6:165-193.
46. Soyka M, Preuss UW, Koller G, Zill P, Bondy B. 2004. Association of 5-HT1B receptor gene and antisocial behavior in alcoholism. J Neural Transm 111(1):101-109.
47. Strobel A, Gutknecht L, Rothe C, Reif A, Mossner R, Zeng Y, et al. 2003. Allelic variation in serotonin transporter function associated with the intensity dependence of the auditory evoked potential. Am J Med Genet Part B Neuropsychiatr Genet 118B(1):41-47.
48. Svenningsson P, Chergui K, Rachleff I, Flajolet M, Zhang X, El Yacoubi M, et al. 2006. Alterations in 5-HT1B receptor function by p11 in depression-like states. Science 311(5757):77-80.
49. Tuchtenhagen F, Daumann J, Norra C, Gobbele R, Becker S, Pelz S, et al. 2000. High intensity dependence of auditory evoked dipole source activity indicates decreased serotonergic activity in abstinent ecstasy (MDMA) users. Neuropsychopharmacol 22:608-617.
50. Wittchen HU, Zaudig M, Fydrich T. 1997. Strukturiertes Klinisches Interview für DSM-IV, Achse I und II. Goettingen: Hogrefe.
51. Zohar J, Kennedy JL, Hollander E, Koran LM. 2004. Serotonin-1D hypothesis of obsessive-compulsive disorder: An update. J Clin Psychiatry 65(14):18-21.